Genome editing

The new synthesis: How synthetic DNA technology is changing drug discovery

10 May 2021

Dr Tim Brears, CEO, Evonetix and Dr Raquel Sanches-Kuiper, Director of Biology, Evonetix explore applications of synthetic DNA in drug discovery and development, the benefits and limitations of current methods, and the opportunities offered by emerging DNA synthesis technologies. On 16 April 16, 1956, Arthur Kornberg and his team of biochemists first isolated the enzyme […]

ERS Genomics and Setsuro Tech sign CRISPR/Cas9 license agreement

11 March 2021

ERS Genomics and Setsuro Tech have announced a non-exclusive license agreement granting Setsuro Tech access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan. Setsuro Tech has developed a high-throughput genome editing method for mammalian embryos, termed genome editing by electroporation of Cas9 protein (GEEP). Using this method, the company is able to generate genetically engineered […]